Literature DB >> 20975776

Lead Fractures in Deep Brain Stimulation during Long-Term Follow-Up.

Fernando Seijo Fernández1, Marco Antonio Alvarez Vega, Aida Antuña Ramos, Fernando Fernández González, Beatriz Lozano Aragoneses.   

Abstract

The purpose was to determine the incidence of lead fracture in patients with DBS over a long period of time. We present a retrospective study of 208 patients who received 387 DBS electrodes. Fourteen patients had sixteen lead fractures (4% of the implanted leads) and two patients suffered from 2 lead fractures. Of all lead fractures, five patients had the connection between the leads and the extension cables located in mastoids region, ten in cervical area and one in thoracic region. The mean distance from the connection between the electrode and the extension cable and the lead fracture was 10.7 mm. The lead fracture is a common, although long-term complication in DBS surgery. In our experience, the most common site of electrode cable breakage is approximately between 9 and 13 mm from the junction between the lead and the extension cable. The most important cause of lead fracture is the rotational movement of the lead-extension cable system. If we suspect lead fracture, we must check the impedance of the electrode and to evaluate the side effects of voltage. Finally, we must conduct a radiological screening.

Entities:  

Year:  2009        PMID: 20975776      PMCID: PMC2957221          DOI: 10.4061/2010/409356

Source DB:  PubMed          Journal:  Parkinsons Dis        ISSN: 2042-0080


1. Introduction

Deep brain stimulation (DBS) utilisedsuccessfully in movement disorders and pain is not exempt from complications. Thus, the incidence of hardware-relatedcomplications affects 13.9% of patients, who underwent surgery [1] and 4.3%–8.4% ofimplanted electrodes per year [2, 3]. The most common complications and percentages are infection in 6.1% of patients, migration or misplacement of the leads in 5.1% of patients, skin erosion in 1.3% of patients and lead fractures in 1%–15% of patients [4-8]. In this article, we will review the long-term incidence of lead fractures in DBS surgery on a total of 387 DBS electrodes implanted from 1996–2007.

2. Objective

Our objective is to determine the long-term incidence of lead fractures in patients who underwent DBS surgery.

3. Methods

This article is a retrospective study, 1996–2007, on a consecutive series of patients who underwent DBS surgery. All patients were operated on by the same surgeon (F.S.) at the same hospital and with the same surgical methodology [9]. Out of a total of 208 patients, 387 DBS electrodes (3387/3389 Medtronic Inc, Minneapolis, MN, USA) were implanted, with 179 patients who received a bilateral implant and 29 who received a unilateral implant. The patients' diagnoses were Parkinson's disease, tremors, dystonias, and cluster headache. The DBS electrodes were implanted in the thalamus, internal pallidus, subthalamic nucleus, and hypothalamus. The connection site between the DBS electrode and the extension cable was the cervical region in 264 connections, the mastoid region in 75, and the thorax in 34. The mean followup period of all cases was 51 months (Range: 6–125). The length of the DBS electrodes depended upon the type of internal pulse generator (IPG) (Soletra or Kinetra, Medtronic Inc, Minneapolis, MN, USA). The majority of connections that were performed in the thorax pertained to the Kinetra IPG. Three patients died during this period due to causes unrelated to the surgery and four patients did not keep in contact with us. All these patients had received the DBS electrode implanted bilaterally and were not included in this article.

4. Results

Between June of 1996 and December of 2007, 22 patients (10.5% of all patients) had complications related to the hardware. These complications were 16 lead fractures, 4 erosions, and 2 infections in the IPG. Out of 22 patients who had complications related to the hardware, fourteen patients, 9 men and 5 women, had 16 lead fractures (4% of the implanted leads) and two patients suffered from 2 lead fractures. The mean age of these patients was 57 years (Range: 28–75 years). The lead fractures were localised with 10 in the cervical region, 5 in the mastoid region, and 1 in the thorax (Figures 1, 2, and 3). The first diagnosis of lead fracture was in October of 2001 and the last in November of 2008. The mean time between the DBS surgery and the diagnosis of lead fracture was 36 months (Range: 7–84 months) and the mean distance from the connection between the electrode and the extension cable and the lead fracture was 10.7 mm (range: 9–13.2 mm); see Table 1.
Figure 1

Lead Fracture with connection located in mastoid region.

Figure 2

Lead fracture with connection located in thoracic region.

Figure 3

Lead fracture with connection located in cervical region.

Table 1

C1, C2, C3, C5, C6: cervical vertebral body. CL: cluster headache. DBS: deep brain stimulation. H: hypothalamus. M: male. F: female. PD: Parkinson's disease. STN: subthalamic nucleus. T1: thoracic vertebral body. VIM: ventralis intermediate nucleus.

Patient/SexDiagnostic/ Place of implant DBSAgeDate of implantDate of breakPlace of breakDistance of break (mm)Conexion model
1MTremors/VIM2801/20/199810/03/2001C512.17495
2ME.P/ NST6305/26/200104/22/2008C39.27495
3FE.P/NST5405/22/200302/01/2006T1,13.227489
05/25/200601/10/2007mastoid9.97489
4FE.P/NST5606/24/200406/01/2006C59.77489
5FE.P/NST6904/14/200501/03/2007C1,11.307489
04/17/200702/21/2008mastoid9.837489
6FCL/H4702/19/200609/04/2007C613.37489
7ME.P/NST4007/05/200601/16/2008C512.397489
8ME.P/NST7503/23/200304/11/2007C29.447489
9ME.P/NST5902/05/200409/10/2008mastoid11.687489
10ME.P/NST5906/14/200709/22//2008mastoid9.527489
11FE.P/NST7206/24/200310/15/2007C59.617489
12ME.P/NST6004/11/200209/10/2007C297489
13ME.P/NST6105/19/200511/19/2008C28.27489
14ME.P/NST5811/03/200506/24/2008mastoid8.87489

5. Discussion

According to the data obtained in literature, the breakage of leads and wires is present in 5% of patients who underwent DBS surgery and in 1.8% of implanted electrodes [4]. We present sixteen lead fractures (4% of the lead implants) in fourteen patients (7% of all cases). In other words, in our experience with 387 implanted electrodes, the most common hardware-related complication was lead fracture. In the case of 12 patients with Parkinson's disease, these patients suffered from an abrupt worsening of their disease: in the case of the patient with cluster headache, the pain returned, and in the case of essential tremor, it reoccurred. In the followup examination, impedance as well as current was measured. In 14 electrodes, impedance exceeded 2000 ohms and two were normal, and in the 16 electrodes checked, no side effects occurred with voltages of 10.5 V. For the purpose of confirming electrode breakage, all patients underwent X-rays and in all cases lead fracture was observed (Figures 1, 2, and 3). In the two cases where impedance was normal on the X-ray of the lead, a change in its structure was observed but without attaining a complete fracture (Figures 4 and 5). Whereas the majority of the authors [2, 6, 10] describe this finding between 6 and 24 months after implanting the electrode, in our case, it was detected at about 36 months (Range: 7–84 months).
Figure 4

Incomplete lead fracture. (a) Rx of skull. (b) Detail of incomplete lead fracture. (c) A distortion of the explanted lead of (a) is observed.

Figure 5

(a) Normal Lead. (b) We observed an explanted lead different from Figure 4.

It is surprising to see that none of the 4 patients with dystonia (out of a total of 208 patients) who underwent DBS surgery experienced electrode breakage [11]. We think that this event is due to the fact that in two cases the result was spectacular and the patients no longer experienced the stereotyped movements typical of dystonia, and in another case, because the dystonia was focal and only affected the upper right extremity, its movements did not have an influence on the trajectory of the lead, and in the fourth case, because even though the movements due to dystonia did not disappear, they did decrease and this put the patient in the same range of electrode breakage as those patients who suffered from Parkinson's disease and who undergo DBS surgery. Why did the breakage fracture always occur at 10.7 mm (range 9–13.2) from the connection between the lead and the extension cable? In the study that we conducted, we observed the following events out of all our cases: (i) All patients who underwent surgery showed a wide loop in the lead at the cranial level. This was done to avoid displacement of the electrode at a cerebral level. (ii) Lead fractures are not related to the type of IPG (Soletra or Kinetra, Medtronic Inc, Minneapolis, MN, USA) or to the type of lead (3387/3389, Medtronic Inc, Minneapolis, MN, USA) or to the length of the extension cable. (iii) The mean time of breakage was long, 36 months. We think that cervical movements transmit flexion-extension movements, but above all, rotation to the extension cable and this transmits those movements to the lead, with the point of maximum force being between 9 and 13 mm from the connection between the extension cable and the lead (Figures 4 and 5). The extension cable could become twisted with movements without breaking because of its greater resistance whereas the lead, being more fragile and anchored to the cranium, would be more affected by the force of these movements. Normal material fatigue with the passage of time must also be kept in mind [12]. The connection between the lead and the extension cable at a cervical level has been associated with a greater incidence of wire fractures [2]. However, in our experience, the percentage rate for breakage fractures in regards to the connection site was at 6.5% (5 cases of 75) in the mastoid region, 3.8% (10 cases of 264) in the cervical region, and 3% (1 case of 34) at the thoracic level. The majority of our connections between the lead and the extension cable were carried out in the cervical region to avoid erosions since they occur more frequently if this procedure is carried out on a hard surface such as the cranium (4). None of our patients in whom the connection was carried out between the lead and the extension cable in the cervical region presented skin erosions.

6. Conclusion

Lead fracture is a common, although long-term complication in DBS surgery. In our experience, the most common site of electrode cable breakage is approximately between 9 and 13 mm from the junction between the lead and the extension cable. We believe that the most important cause of lead fracture is the rotational movement of the lead-extension cable system. If we suspect lead fracture, we must check the impedance of the electrode and to evaluate the side effects of voltage. Finally, we must conduct a radiological screening.
  12 in total

1.  Hardware-related problems of deep brain stimulation.

Authors:  Carole Joint; Dipankar Nandi; Simon Parkin; Ralph Gregory; Tipu Aziz
Journal:  Mov Disord       Date:  2002       Impact factor: 10.338

2.  Hardware-related complications after placement of thalamic deep brain stimulator systems.

Authors:  Douglas Kondziolka; Donald Whiting; Anand Germanwala; Michael Oh
Journal:  Stereotact Funct Neurosurg       Date:  2002       Impact factor: 1.875

3.  Increased risk of lead fracture and migration in dystonia compared with other movement disorders following deep brain stimulation.

Authors:  J Yianni; D Nandi; A Shad; P Bain; Ralph Gregory; Tipu Aziz
Journal:  J Clin Neurosci       Date:  2004-04       Impact factor: 1.961

4.  Hardware-related complications of deep brain stimulation: a ten year experience.

Authors:  P Blomstedt; M I Hariz
Journal:  Acta Neurochir (Wien)       Date:  2005-07-25       Impact factor: 2.216

5.  Operative and hardware complications of deep brain stimulation for movement disorders.

Authors:  A Paluzzi; A Belli; P Bain; X Liu; T M Aziz
Journal:  Br J Neurosurg       Date:  2006-10       Impact factor: 1.596

Review 6.  Hardware-related complications of deep brain stimulation: a review of the published literature.

Authors:  Clement Hamani; Andres M Lozano
Journal:  Stereotact Funct Neurosurg       Date:  2006-10-23       Impact factor: 1.875

7.  Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease.

Authors:  R R Goodman; B Kim; S McClelland; P B Senatus; L M Winfield; S L Pullman; Q Yu; B Ford; G M McKhann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

8.  Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery--experiences from a single centre.

Authors:  J Voges; Y Waerzeggers; M Maarouf; R Lehrke; A Koulousakis; D Lenartz; V Sturm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

9.  Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures.

Authors:  F J Seijo; M A Alvarez-Vega; J C Gutierrez; F Fdez-Glez; B Lozano
Journal:  Acta Neurochir (Wien)       Date:  2007-08-14       Impact factor: 2.216

10.  Deep brain stimulation hardware complications: the role of electrode impedance and current measurements.

Authors:  Sierra Farris; Jerrold Vitek; Monique L Giroux
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

View more
  3 in total

1.  Update on deep brain stimulation in Parkinson's disease.

Authors:  Daniel Martinez-Ramirez; Wei Hu; Alberto R Bona; Michael S Okun; Aparna Wagle Shukla
Journal:  Transl Neurodegener       Date:  2015-06-27       Impact factor: 8.014

2.  Management of Elevated Therapeutic Impedances on Deep Brain Stimulation Leads.

Authors:  Wissam Deeb; Amar Patel; Michael S Okun; Aysegul Gunduz
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-21

3.  Towards unambiguous reporting of complications related to deep brain stimulation surgery: A retrospective single-center analysis and systematic review of the literature.

Authors:  Katja Engel; Torge Huckhagel; Alessandro Gulberti; Monika Pötter-Nerger; Eik Vettorazzi; Ute Hidding; Chi-Un Choe; Simone Zittel; Hanna Braaß; Peter Ludewig; Miriam Schaper; Kara Krajewski; Christian Oehlwein; Katrin Mittmann; Andreas K Engel; Christian Gerloff; Manfred Westphal; Christian K E Moll; Carsten Buhmann; Johannes A Köppen; Wolfgang Hamel
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.